Previous research on tissue-engineered blood vessels(TEBVs)has mainly focused on the intima or adventitia unilaterally,neglecting the equal importance of both layers.Meanwhile,the efficacy of grafts modified with vasc...Previous research on tissue-engineered blood vessels(TEBVs)has mainly focused on the intima or adventitia unilaterally,neglecting the equal importance of both layers.Meanwhile,the efficacy of grafts modified with vascular endothelial growth factor(VEGF)merely has been limited.Here,we developed a small-diameter graft that can gradually release VEGF andγsecretase inhibitor IX(DAPT)to enhance tissue regeneration and remodeling in both the intima and adventitia.In vitro,experiments revealed that the combination of VEGF and DAPT had superior pro-proliferation and pro-migration effects on endothelial cells.In vivo,the sustained release of VEGF and DAPT from the grafts resulted in improved regeneration and remodeling.Specifically,in the intima,faster endothelialization and regeneration of smooth muscle cells led to higher patency rates and better remodeling.In the adventitia,a higher density of neovascularization,M2 macrophages and fibroblasts promoted cellular ingrowth and replacement of the implant with autologous neo-tissue.Furthermore,western blot analysis confirmed that the regenerated ECs were functional and the effect of DAPT was associated with increased expression of vascular endothelial growth factor receptor 2.Our study demonstrated that the sustained release of VEGF and DAPT from the graft can effectively promote tissue regeneration and remodeling in both the intima and adventitia.This development has the potential to significantly accelerate the clinical application of small-diameter TEBVs.展开更多
基金supported by the National Natural Science Foundation of China(Grant No.81974178)Introduced and Jointly Built High-end R&D Institute of Jiangxi.(Grant No.20203CCH45008)Science and Technology Program of Guangzhou,China(Grant No.202201010969).
文摘Previous research on tissue-engineered blood vessels(TEBVs)has mainly focused on the intima or adventitia unilaterally,neglecting the equal importance of both layers.Meanwhile,the efficacy of grafts modified with vascular endothelial growth factor(VEGF)merely has been limited.Here,we developed a small-diameter graft that can gradually release VEGF andγsecretase inhibitor IX(DAPT)to enhance tissue regeneration and remodeling in both the intima and adventitia.In vitro,experiments revealed that the combination of VEGF and DAPT had superior pro-proliferation and pro-migration effects on endothelial cells.In vivo,the sustained release of VEGF and DAPT from the grafts resulted in improved regeneration and remodeling.Specifically,in the intima,faster endothelialization and regeneration of smooth muscle cells led to higher patency rates and better remodeling.In the adventitia,a higher density of neovascularization,M2 macrophages and fibroblasts promoted cellular ingrowth and replacement of the implant with autologous neo-tissue.Furthermore,western blot analysis confirmed that the regenerated ECs were functional and the effect of DAPT was associated with increased expression of vascular endothelial growth factor receptor 2.Our study demonstrated that the sustained release of VEGF and DAPT from the graft can effectively promote tissue regeneration and remodeling in both the intima and adventitia.This development has the potential to significantly accelerate the clinical application of small-diameter TEBVs.
